Raiffeisen Bank International AG Increases Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Raiffeisen Bank International AG raised its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 67.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,646 shares of the company's stock after purchasing an additional 2,674 shares during the period. Raiffeisen Bank International AG's holdings in HCA Healthcare were worth $2,274,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently modified their holdings of the company. Cheviot Value Management LLC bought a new position in HCA Healthcare during the first quarter valued at $26,000. Atwood & Palmer Inc. bought a new position in HCA Healthcare during the 1st quarter valued at about $28,000. Bartlett & CO. Wealth Management LLC lifted its stake in HCA Healthcare by 888.9% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 89 shares of the company's stock worth $31,000 after purchasing an additional 80 shares during the last quarter. ORG Partners LLC grew its stake in shares of HCA Healthcare by 344.0% during the first quarter. ORG Partners LLC now owns 111 shares of the company's stock valued at $38,000 after buying an additional 86 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. boosted its holdings in HCA Healthcare by 75.8% during the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 116 shares of the company's stock valued at $40,000 after acquiring an additional 50 shares during the period. Institutional investors own 62.73% of the company's stock.

Insider Activity

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the company's stock in a transaction on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the completion of the sale, the chief operating officer directly owned 12,646 shares in the company, valued at $4,670,420.72. This represents a 55.38% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. 1.30% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on HCA. Royal Bank Of Canada set a $401.00 target price on shares of HCA Healthcare and gave the company an "outperform" rating in a research note on Monday, July 28th. Barclays cut their price target on HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating on the stock in a report on Monday, July 28th. Guggenheim began coverage on shares of HCA Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating for the company. Bank of America downgraded shares of HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 price objective on the stock. in a report on Wednesday, July 16th. Finally, Truist Financial lifted their price target on HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a research report on Wednesday, July 16th. Nine equities research analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $396.46.

HCA Healthcare Stock Performance

HCA opened at $356.84 on Monday. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The company has a quick ratio of 0.86, a current ratio of 0.98 and a debt-to-equity ratio of 69.07. The firm's fifty day simple moving average is $370.66 and its two-hundred day simple moving average is $347.68. The company has a market cap of $85.84 billion, a price-to-earnings ratio of 15.00, a PEG ratio of 1.12 and a beta of 1.39.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%. The business had revenue of $18.61 billion during the quarter, compared to analysts' expectations of $18.49 billion. During the same quarter in the prior year, the firm earned $5.50 earnings per share. The business's revenue was up 6.4% compared to the same quarter last year. Equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th will be given a $0.72 dividend. The ex-dividend date is Tuesday, September 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare's dividend payout ratio is 12.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.